TY  - CHAP
M1  - Book, Section
TI  - Vitreous Hemorrhage
A1  - Duncan, Jacque L.
A1  - Parikh, Neeti B.
A1  - Seitzman, Gerami D.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2022
T2  - Current Medical Diagnosis & Treatment 2022
AB  - Patients  with  vitreous  hemorrhage  complain  of  sudden  visual  loss,  abrupt  onset  of  floaters  that  may  progressively  increase  in  severity,  or  occasionally,  “bleeding  within  the  eye.”  Visual  acuity  ranges  from  20/20  (6/6)  to  light  perception.  The  eye  is  not  inflamed,  red,  or  painful,  and  clues  to  diagnosis  are  inability  to  see  fundus  details  or  localized  collection  of  blood  in  the  vitreous,  in  front  of  the  retina  (eFigure  7–43).  Causes  of  vitreous  hemorrhage  include  retinal  tear  (with  or  without  detachment),  diabetic  or  sickle  cell  retinopathy,  retinal  vein  occlusion,  retinal  vasculitis,  neovascular  age-related  macular  degeneration,  retinal  arterial  macroaneurysm,  blood  dyscrasia,  therapeutic  anticoagulation,  trauma,  subarachnoid  hemorrhage,  and  severe  straining  (Valsalva  retinopathy).  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/16
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1184192256
ER  -